Clinical Trials on Retinal Detachment in Switzerland

Total 279 results

Francine Behar-Cohen
Emory University; University of Lausanne Hospitals

Completed

Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment (UDCA-RD)

Rhegmatogenous Retinal Detachment

Switzerland
Berner Augenklinik

Enrolling by invitation

Impact of ILM Peeling in RRD/ I-Peel (I-Peel)

Retinal Detachment

Switzerland
University Hospital Inselspital, Berne

Terminated

Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment

Retinal Detachment

Switzerland
University Hospital Inselspital, Berne

Recruiting

High Resolution Optical Coherence Tomography

Glaucoma | Macular Degeneration | Uveitis | Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Retinal Vein Occlusion | Optic Nerve Diseases | Retinal Detachment | Macular Disease | Retinal Disease | Retinal Neovascularization | Retinal Artery Occlusion | Hypertensive Retinopathy | Retinal Edema | Retinal Dystrophy

Switzerland
Moser Christophe
Institut National de la Santé Et de la Recherche Médicale, France; Eye Hospital...

Completed

Retinal Imaging With Oblique Illumination (ASSESS)

Retinal Disease

Switzerland
Insel Gruppe AG, University Hospital Bern
Bern University of Applied Sciences

Recruiting

Evaluating the Safety of the SPECTRALIS CENTAURUS Device (CENTAURUS)

Retinal Diseases

Switzerland
University Hospital Inselspital, Berne
University of Bern; Haag-Streit AG

Not yet recruiting

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI) (STARFLI)

Retinal Disease

Switzerland
University Hospital Inselspital, Berne

Completed

Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)

Retinal Disease

Switzerland
Luzerner Kantonsspital

Completed

RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders (CEL01LUKS)

Retinal Disease | Eye Disease

Switzerland
Centervue SpA

Active, not recruiting

Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology

Retinal Diseases | Healthy Eyes

Switzerland
University of Bern
University Hospital, Zürich; ISS AG

Completed

Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01)

Macular Degeneration

Switzerland
University of Zurich

Completed

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Macular Degeneration

Switzerland
University Hospital, Basel, Switzerland

Completed

Oxidative Stress in Patients With Age-Related Macular Degeneration

Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Completed

The Role of Macular Pigment in Patients With Age-related Macular Degeneration

Age Related Maculopathy

Switzerland
University Hospital Inselspital, Berne

Completed

Enhancement of Macular Pigment Density by Oral Lutein Supplementation (EMPOLS)

Age-Related Maculopathies

Switzerland
Sebastian Wolf
University of Bern

Completed

Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

Macular Edema | CNV

Switzerland
Berner Augenklinik
medignition AG

Enrolling by invitation

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD (SPARROW)

Wet Age-related Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)

Age Related Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Completed

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment (FLOS)

Age Related Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Completed

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Age Related Macular Degeneration

Switzerland
Novartis Pharmaceuticals

Completed

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Intraocular Inflammation | Retinal Vascular Occlusion

Switzerland
European School of Advanced Studies in Ophthalmology

Completed

Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome

Diabetic Macular Edema

Switzerland
University Hospital Inselspital, Berne

Terminated

Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study) (AVOCT)

Diabetic Macular Edema

Switzerland
University Hospital Inselspital, Berne
University of Bern

Completed

Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema

Diabetic Macular Edema

Switzerland
ThromboGenics

Completed

A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Retinal Telangiectasis | Idiopathic Juxtafoveal Retinal Telangiectasia

France, Switzerland
Novartis

Completed

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement (RESOLVE)

Diabetic Macular Edema

Switzerland
Augenklinik Zurich West
Apellis Pharmaceuticals, Inc.

Recruiting

Virtual Reality Based Vision Test in Patients With AMD (GA-001)

Age-Related Macular Degeneration

Switzerland
University Hospital Inselspital, Berne

Terminated

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Age-related Macular Degeneration | Macular Edema | Retinal Vein Occlusion | Central Serous Chorioretinopathy | Retinal Neovascularization

Switzerland
Dr. med. Katja Hatz
Vista Klinik

Completed

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients (COSP)

Macular Degeneration

Switzerland
Kubota Vision Inc.

Completed

Evaluation of the Retinal Health Monitoring System Thickness Module

Macular Degeneration | Macular Edema

Switzerland
University Hospital Inselspital, Berne
Novartis

Completed

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Age Related Macular Degeneration

Switzerland
Bayer
Regeneron Pharmaceuticals

Completed

Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients (ASTERIA)

Wet Age-related Macular Degeneration

Switzerland
European School of Advanced Studies in Ophthalmology

Completed

Influence of Cataract Surgery on Early DME The DICAT-II Study (DICAT-II)

Diabetic Macular Edema | Cataract Senile | Surgery--Complications

Switzerland
Dr. med. Katja Hatz
Cenaug Foundation

Completed

Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

Neovascular Age-related Macular Degeneration

Switzerland
Vista Klinik
Novartis

Terminated

Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept (ROBIN)

Neovascular Age-related Macular Degeneration

Switzerland
Okuvision GmbH
CONET GmbH - Clinical Operations Network

Completed

Retrospective NIS to Evaluate the Patient Benefit of TES

Retinitis Pigmentosa

Germany, Switzerland
University Hospital, Basel, Switzerland
Medical University of Graz; University of Pittsburgh; Ludwig-Maximilians - University... and other collaborators

Unknown

Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy

Macular Edema

Austria, Switzerland
University of Zurich

Unknown

Incidence of Sub-clinical Cystoid Macular Edema After Cataract Surgery (ICCME)

Glaucoma | Cataract

Switzerland
Vista Klinik

Completed

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Novartis
QLT Inc.

Completed

Photodynamic Therapy in Occult-Only Lesions (POOL)

Age-Related Macular Degeneration

Switzerland
Novartis

Completed

Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) (EXCITE)

Age Related Macular Degeneration

Switzerland
Novartis

Completed

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Novartis

Completed

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Age-Related Macular Degeneration (ARMD)

Switzerland
Boehringer Ingelheim

Terminated

Global Atrophie Biomarker Evaluation Study (GABiE) (GABiE)

Age-related Macular Degeneration

United States, Switzerland
University Hospital Inselspital, Berne

Completed

Nutritional Assessment in Mitochondrial Cytopathy (NAMITO)

Mitochondrial Diseases | Mitochondrial Myopathies | Mitochondrial Cytopathies

Switzerland
Vista Klinik

Completed

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
University Hospital, Basel, Switzerland

Completed

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Age-Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Institute of Molecular and Clinical Ophthalmology...

Recruiting

Function and Imaging Assessments for G1961E-associated Stargardt Disease (FIRSTORBIT)

Stargardt Disease | Stargardt Disease 1 | Fundus Flavimaculatus | Macular Degeneration, Stargardt | Macular Dystrophy With Flecks, Type 1

Switzerland
Prof. Beck Popovic Maja

Terminated

A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma (EuRbG2018)

Eye Cancer, Retinoblastoma

Switzerland
University Hospital, Basel, Switzerland
Institute of Molecular and Clinical Ophthalmology Basel

Recruiting

EyeConic: Qualification for Cone-Optogenetics

Retinal Dystrophies

United States, Switzerland, China, Germany, Hungary, Italy, United Kingdom

Clinical Trials on Retinal Detachment in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations